相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms
Giovanni Martinotti et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Melatonin and neurotrophins NT-3, BDNF, NGF in patients with varying levels of depression severity
Ewa A. Oglodek et al.
PHARMACOLOGICAL REPORTS (2016)
Effect of Mirtazapine Treatment on Serum Levels of Brain-Derived Neurotrophic Factor and Tumor Necrosis Factor-α in Patients of Major Depressive Disorder with Severe Depression
Rachna Gupta et al.
PHARMACOLOGY (2016)
The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
Andre F. Carvalho et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2016)
Pathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic Review
Ke Ma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Antidepressant Compounds Can Be Both Pro- and Anti-Inflammatory in Human Hippocampal Cells
Mark Abie Horowitz et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Comparison of efficacy, safety and brain derived neurotrophic factor (BDNF) levels in patients of major depressive disorder, treated with fluoxetine and desvenlafaxine
R. Ghosh et al.
ASIAN JOURNAL OF PSYCHIATRY (2015)
Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity
Francesca Calabrese et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Depressive-like behaviour induced by an intracerebroventricular injection of streptozotocin in mice: the protective effect of fluoxetine, antitumour necrosis factor-α and thalidomide therapies
Leandro C. Souza et al.
BEHAVIOURAL PHARMACOLOGY (2013)
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials
Markus Koesters et al.
BRITISH JOURNAL OF PSYCHIATRY (2013)
Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatine
Raffaella Molteni et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial
Emmanuelle Corruble et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Antidepressant effects of TNF-α blockade in an animal model of depression
Ute Kruegel et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
A review of the adverse effects and safety of noradrenergic antidepressants
Eromona Whiskey et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Effects of central and peripheral inflammation on hippocampal synaptic plasticity
Massimiliano Di Filippo et al.
NEUROBIOLOGY OF DISEASE (2013)
Cytokines and brain excitability
Michael A. Galic et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2012)
Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression
Yang Liu et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder A Pilot Study
Giovanni Martinotti et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Depressive-like behavior induced by tumor necrosis factor-alpha in mice
Manuella P. Kaster et al.
NEUROPHARMACOLOGY (2012)
The Costs of Depression
Ronald C. Kessler
PSYCHIATRIC CLINICS OF NORTH AMERICA (2012)
Novel melatonin-based therapies: potential advances in the treatment of major depression
Ian B. Hickie et al.
LANCET (2011)
The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
Jonas Hannestad et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Serum BDNF levels before treatment predict SSRI response in depression
Owen M. Wolkowitz et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Mode of action of agomelatine: Synergy between melatonergic and 5-HT2C receptors
Giorgio Racagni et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2011)
A Meta-Analysis of Cytokines in Major Depression
Yekta Dowlati et al.
BIOLOGICAL PSYCHIATRY (2010)
Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study
Anthony Hale et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder: A Randomized, Double-Blind Comparison With Sertraline
Siegfried Kasper et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration
Raffaella Molteni et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2010)
Problems associated with long-term treatment with selective serotonin reuptake inhibitors
C. Moret et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients
Ayse Devrim Basterzi et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications
Srijan Sen et al.
BIOLOGICAL PSYCHIATRY (2008)
A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR
Sidney H. Kennedy et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Serum brain-derived neurotrophic factor levels in patients with major depression: Effects of antidepressants
Tiao-Lai Huang et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine
Francesco Matrisciano et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants
Hwa-Young Lee et al.
NEUROPSYCHOBIOLOGY (2008)
Peripheral lipopolysaccharide administration transiently affects expression of brain-derived neurotrophic factor, corticotropin and proopiomelanocortin in mouse brain
Sabine Schnydrig et al.
NEUROSCIENCE LETTERS (2007)
Cytokine imbalance in the pathophysiology of major depressive disorder
Yong-Ku Kim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Circadian genes, rhythms and the biology of mood disorders
Colleen A. McClung
PHARMACOLOGY & THERAPEUTICS (2007)
Sleep and circadian rhythms in mood disorders
R. Armitage
ACTA PSYCHIATRICA SCANDINAVICA (2007)
Placebo-controlled trial of agomelatine in the treatment of major depressive disorder
SH Kennedy et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats
ZW Guan et al.
BRAIN BEHAVIOR AND IMMUNITY (2006)
Cytokines and major depression
OJG Schiepers et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Critical role of brain-derived neurotrophic factor in mood disorders
K Hashimoto et al.
BRAIN RESEARCH REVIEWS (2004)
Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants
E Shimizu et al.
BIOLOGICAL PSYCHIATRY (2003)
Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder
C Tuglu et al.
PSYCHOPHARMACOLOGY (2003)
Cytokine-induced changes in mood and behaviour: implications for depression due to a general medical condition, immunotherapy and antidepressive treatment
Y Pollak et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2002)
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability
IM Anderson
JOURNAL OF AFFECTIVE DISORDERS (2000)
分享论文
